Development and initial validation of international severity scoring system for familial Mediterranean fever (ISSF)

Annals of the Rheumatic Diseases

Volumn 75, Issue 6, 2016, Pages 1051-1056

  Demirkaya, Erkan ^a   Acikel, Cengizhan ^a   Hashkes, Philip ^b   Gattorno, Marco ^c   Gul, Ahmet ^d   Ozdogan, Huri ^d   Turker, Turker ^a   Karadag, Omer ^e   Livneh, Avi ^f   Ben Chetrit, Eldad ^g   Ozen, Seza ^e  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b SHAARE ZEDEK MEDICAL CENTER   (Israel)

^c G GASLINI INSTITUTE   (Italy)

^d ISTANBUL UNIVERSITY   (Turkey)

^e HACETTEPE UNIVERSITY   (Turkey)

^f TEL AVIV UNIVERSITY   (Israel)

^g HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CONSENSUS; DELPHI STUDY; DISEASE SEVERITY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMAN; INTERNATIONAL SEVERITY SCORE FAMILIAL MEDITERRANEAN FEVER; MAJOR CLINICAL STUDY; MALE; PEDIATRICIAN; PHYSICIAN GLOBAL ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; VALIDITY; INFANT; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX; VALIDATION STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DELPHI TECHNIQUE; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMANS; INFANT; MALE; ROC CURVE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84962177688     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2015-208671     Document Type: Article

References (33)

1. Polat A, Demirkaya E, Basbozkurt G, et al., FMF Arthritis Vasculitis and Orphan disease Research in Paediatric Rheumatology (FAVOR). A Glance at History and Future Perspectives of Childhood Autoinflammatory Disorders. Ann Paediatr Rheum 2012;1:17-30.
2. Saglam C, Polat A, Jones OY, et al. Recent advances in the management of children with familial Mediterranean fever. Int J Clin Rheumatol 2013;8:233-45.
3. Demirkaya E, Livneh A. Evaluation of the current disease scoring systems in familial mediterranean fever. Familial mediterranean fever. Springer, 2015:107-18.
4. Buskila D, Zaks N, Neumann L, et al. Quality of life of patients with familial Mediterranean fever. Clin Exp Rheumatol 1997;15:355-60.
5. Pras E, Livneh A, Balow JE Jr, et al. Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet 1998;75:216-19.
6. Mor A, Shinar Y, Zaks N, et al. Evaluation of disease severity in familial Mediterranean fever. Semin Arthritis Rheum 2005;35:57-64.
7. Kalkan G, Demirkaya E, Acikel CH, et al. Evaluation of the current disease severity scores in paediatric FMF: is it necessary to develop a new one? Rheumatology (Oxford) 2012;51:743-8.
8. Livneh A. Diagnosis. Severity scoring system for paediatric FMF. Nat Rev Rheumatol 2012;8:309-10.
9. Kalkan G, Demirkaya E, Ozen S. Severity scoring system for paediatric FMF. Nat Rev Rheumatol 2012;8:621.
10. Ruperto N, Pistorio A, Ravelli A, et al. Criteria to define response to therapy in paediatric rheumatic diseases. Eur J Clin Pharmacol 2011;67(Supplement 1):125-31.
11. Ruperto N, Meiorin S, Iusan SM, et al. Consensus procedures and their role in pediatric rheumatology. Curr Rheumatol Rep 2008;10:142-6.
12. Sohar E, Gafni J, Pras M, et al. Familial Mediterranean fever. Am J Med 1967;43:227-53.
13. Yalçinkaya F, Ozen S, Ozçakar ZB, et al. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology (Oxford) 2009;48:395-8.
14. Kirwan JR, Boers M, Tugwell P. Updating the OMERACT filter at OMERACT 11. J Rheumatol 2014;41:975-7.
15. Tugwell P, Boers M, D'Agostino MA 3rd, et al. Updating the OMERACT filter: implications of filter 2.0 to select outcome instruments through assessment of "truth": content, face, and construct validity. J Rheumatol 2014;41:1000-4.
16. Jeske M, Lohse P, Kallinich T, et al. Genotype-phenotype and genotype-origin correlations in children with mediterranean fever in Germany - an AID-net study. Klin Padiatr 2013;225:325-30.
17. Ozen S, Aktay N, Lainka E, et al. Disease severity in children and adolescents with familial Mediterranean fever: a comparative study to explore environmental effects on a monogenic disease. Ann Rheum Dis 2009;68:246-8.
18. Goldstein RC, Schwabe AD. Prophylactic colchicine therapy in familial Mediterranean fever. A controlled, double-blind study. Ann Intern Med 1974;81:792-4.
19. Zemer D, Revach M, Pras M, et al. A controlled trial of colchicine in preventing attacks of familial mediterranean fever. N Engl J Med 1974;291:932-4.
20. Hashkes PJ, Spalding SJ, Giannini EH, et al. Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial. Ann Intern Med 2012;157:533-41.
21. Wright DG, Wolff SM, Fauci AS, et al. Efficacy of intermittent colchicine therapy in familial Mediterranean fever. Ann Intern Med 1977;86:162-5.
22. Amaryan G, Astvatsatryan V, Gabrielyan E, et al. Double-blind, placebo-controlled, randomized, pilot clinical trial of ImmunoGuard--a standardized fixed combination of Andrographis paniculata Nees, with Eleutherococcus senticosus Maxim, Schizandra chinensis Bail. and Glycyrrhiza glabra L. extracts in patients with Familial Mediterranean Fever. Phytomedicine 2003;10:271-85.
23. Dinarello CA, Wolff SM, Goldfinger SE, et al. Colchicine therapy for familial mediterranean fever. A double-blind trial. N Engl J Med 1974;291:934-7.
24. Tunca M, Akar S, Soytürk M, et al. The effect of interferon alpha administration on acute attacks of familial Mediterranean fever: a double-blind, placebo-controlled trial. Clin Exp Rheumatol 2004;22(Supplement 34):S37-40.
25. Giese A, Örnek A, Kilic L, et al. Disease severity in adult patients of Turkish ancestry with familial mediterranean fever living in Germany or Turkey. Does the country of residence affect the course of the disease? J Clin Rheumatol 2013;19:246-51.
26. Ozen S, Demirkaya E, Amaryan G, et al. Results from a multicentre international registry of familial Mediterranean fever: impact of environment on the expression of a monogenic disease in children. Ann Rheum Dis 2014;73:662-7.
27. Tufan A, Aydin SZ, Eren F, et al. Frequency and disease severity of familial mediterranean fever (FMF) related MEFV gene mutations among ankylosing spondylitis patients. Turkiye Klinikleri J Med Sci 2014;34:223-30.
28. Press J, Shinar Y, Langevitz P, et al. Familial Mediterranean fever in two Bedouin families: mutation analysis and disease severity. Am J Med Genet 2000;92:247-9.
29. Makay B, Unsal E. Does breast-feeding affect severity of familial Mediterranean fever? Clin Rheumatol 2009;28:1389-93.
30. Lidar M, Kedem R, Berkun Y, et al. Familial Mediterranean fever in Ashkenazi Jews: the mild end of the clinical spectrum. J Rheumatol 2010;37:422-5.
31. Ben-Zvi I, Herskovizh C, Kukuy O, et al. Familial Mediterranean fever without MEFV mutations: a case-control study. Orphanet J Rare Dis 2015;10:34.
32. Padeh S, Shinar Y, Pras E, et al. Clinical and diagnostic value of genetic testing in 216 Israeli children with Familial Mediterranean fever. J Rheumatol 2003;30:185-90.
33. Ben-Zvi I, Krichely-Vachdi T, Feld O, et al. Colchicine-free remission in familial Mediterranean fever: featuring a unique subset of the disease-a case control study. Orphanet J Rare Dis 2014;9:3.